Header

Skip to main content

MaxCyte

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.

MEDIPOST America

MEDIPOST provides services and develops products related to a readily available and non-controversial source – human umbilical cord blood and human Umbilical Cord Blood derived Mesenchymal Stem Cells (hUCB-MSCs), respectively.

Arcellx

Arcellx is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies.

AbelZeta

AbelZeta is a biopharmaceutical company that develops immune cell therapies for the treatment of cancerous diseases.

Addimmune

Addimmune is a clinical-stage gene and cell therapy company developing a functional cure for HIV. It is developing a single-dose lentiviral-based autologous cell therapy.

This website uses cookies

This site uses cookies to provide more personalized content, social media features, and ads, and to analyze our traffic. We might share information about your use of our site with our social media, advertising, and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will never sell your information or share it with unaffiliated entities.